AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2011
Dec 12, 2011
34931_dirs_2011-12-12_bccd3db8-3e0f-4031-a0ae-fb0bc1d991bc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-12-08
Reporting Person: GREENACRE MARTYN D (Director)
More from LISATA THERAPEUTICS, INC.
Merger & Acquisition
2026
May 29
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3